B. Riley Financial Declares Preferred Stock Dividends
LOS ANGELES, July 7, 2022 /PRNewswire/ -- B. Riley Financial, Inc. (NASDAQ: RILY) has declared cash dividends on its 6.875% Series A Cumulative Perpetual Preferred Stock (NASDAQ: RILYP) and its 7.375% Series B Cumulative Perpetual Preferred Stock (NASDAQ: RILYL) (collectively, the "Preferred Stock"), each series of which is represented by depositary shares. Each depositary share represents 1/1000th fractional interest in a share of the respective Preferred Stock with a liquidation preference equivalent to $25.00 per depositary share.
RILY) logo (PRNewsfoto/B. Riley Financial)" alt="B. Riley Financial, Inc. (Nasdaq: RILY) logo (PRNewsfoto/B. Riley Financial)" />
The 6.875% Series A Preferred Stock cash dividend equals $0.42968750 per depositary share.
The 7.375% Series B Preferred Stock cash dividend equals $0.4609375 per depositary share.
The Preferred Stock dividends will be payable on or about July 29, 2022 to respective Series A and Series B holders of record as of the close of business on July 19, 2022.
B. Riley Financial is a diversified financial services platform that delivers tailored solutions to meet the strategic, operational, and capital needs of its clients and partners. Through its affiliated subsidiaries, B. Riley provides end-to-end, collaborative financial services across investment banking, institutional brokerage, private wealth and investment management, financial consulting, corporate restructuring, operations management, risk and compliance, due diligence, forensic accounting, litigation support, appraisal and valuation, auction, and liquidation services. For more information, please visit www.brileyfin.com.
Contacts
Investors | Media |
Mike Frank | Jo Anne McCusker |
(212) 409-2424 | (646) 885-5425 |
View original content to download multimedia:https://www.prnewswire.com/news-releases/b-riley-financial-declares-preferred-stock-dividends-301582093.html
SOURCE B. Riley Financial
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Aolani and Rafay Collaborate on One of the Industry's First NVIDIA DSX OS Deployments on NVIDIA GB200 NVL72 Infrastructure
- New Online Resource Hub Empowers Gallbladder Cancer Patients and Caregivers with Critical Guidance and Support
- Ascentage Pharma Chairman and CEO Dr. Dajun Yang Named to The Medicine Maker Power List 2026
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesRelated Entities
B. Riley, DividendSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share